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257 Challenges in CFRD: The advantages of continuous glucose
monitoring (CGM)
P. Dyce1, C. Sumner1, V. Malone1, D. Nazareth1, M. Walshaw1. 1Liverpool Heart
and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom
Introduction: With survival increasing in CF, CF-related diabetes (CFRD) and its
assocated complications are more common. Achieving optimal glycaemic control
can be particularly difﬁcult despite traditional management methods. CGM provides
greater insight into glycaemic trends through the day, and helps determine the
beneﬁts of treatment changes. We routinely use CGM for optimisation of diabetic
control at our large CF centre (n = 282; 40% CFRD), and have explored its utility
in the management of this CF complication.
Method: We evaluated CGM traces in 29 CFRD patients over a 20 month period,
along with any subsequent changes in weight, pulmonary function, HBA1C and
antibiotic treatment. Food and exercise diaries completed during CGM were also
evaluated.
Results: See Table [Mean (SD)]: 69% gained weight, 72% improved their lung
function (p< 0.0001) and 62% improved HBA1C (p< 0.0001). Overall, 45% re-
quired less IV antibiotic therapy (p< 0.0001) and 34% required fewer oral antibiotic
courses. 90% of subjects had dietary adjustments following review of food and
exercise diaries. 34% had a change in the type of insulin prescribed following
CGM.
Conclusion: This study demonstrates the utility of CGM to improve clinical status
and optimize treatment including the dosage and type of insulin therapy. CGM
used in conjunction with good education, support and the concurrent mapping of
food and exercise diaries is of educational beneﬁt allowing the ﬁne-tuning of any
adjustments of treatment.
Group FEV1 (%) Weight (kg) HBA1C
(IFCCmmol/mol)
Oral Antibiotics
(n courses)
IV Antibiotics
(n courses)
Pre-CGM 56 (29) 58 (12) 63 (28) 0.69 1.1
Post-CGM 61 (28) 59 (12) 55 (16) 0.41 0.64
Values are mean (SD).
258 Has the age of diagnosis of cystic ﬁbrosis related diabetes
(CFRD) changed over the last 10 years?
W. Kent1, P. Dyce1, R. Sarkar1, A. Wight1, M. Ledson1, M. Walshaw1. 1Liverpool
Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom
Introduction: Glucose intolerance is a universal feature in CF, and an early
diagnosis of CFRD is essential to prevent the clinical deterioration that occurs
before standard deﬁnitions of diabetes mellitus are reached. As part of this, we
have put in place a robust system to assess glucose intolerance, and wished to
assess the effect this has had on the diagnosis of this common complication of the
CF condition in our large adult clinic (280 patients).
Methods: We monitored the prevalence of CFRD in our clinic between 2002 and
2012, looking for trends in age at diagnosis and the proportion with the disease.
Results: See table. Over the decade, our clinic has almost doubled in size and the
proportion with CFRD has increased year on year from 13.5% to over 40%, and in
total 155 had CFRD (76 male). There was no difference in age at diagnosis (males:
median 24 years (SD 7.80); females 23 (6.62); p = 0.58).
Table: Median age of CFRD diagnosis, 2000–2012
2002 2004 2006 2008 2010 2012
Median age at diagnosis 31 22 22.5 26 23.5 24
% of clinic with CFRD (number) 13.5
(20)
26.3
(45)
31.1
(63)
32
(76)
38
(99)
43.6
(120)
Proportion of eligible patients
diagnosed in-year (%)
3.9 14.3 5.8 6.2 6.8 8.1
Conclusion: There has been an increase in the percentage of patients with CFRD
over the last decade which is likely to be due to our increased vigilance for
signiﬁcant glucose intolerance. Furthermore, the variation in the median age at
diagnosis indicates that this has occurred throughout the age range of our clinic.
It is important that a diagnosis of CFRD is made in a timely fashion due to the
potential for intervention and effect on patient outcomes.
259 The diurnal variation in glucose handling in CF − Is a change in
guidance needed?
D. Nazareth1, P. Dyce1, V. Malone1, M. Walshaw1. 1Liverpool Adult CF Unit,
Liverpool, United Kingdom
Objectives: Glucose intolerance later in the day may be an early sign of diabetes
[1] and this may be particularly important in CF, where glucose handling is
deﬁcient even in those without established CF-related diabetes (CFRD). However,
the recommended single point diagnostic test, the OGTT, is not physiological and
a CF diet often exceeds this glucose load. We used continuous glucose monitoring
(CGM) to study any diurnal variation of glucose handing in CF in normal daily
life.
Method: 72-hour CGM tracings from 17 CF patients not known to have CFRD
were reviewed for variation in glycaemic levels (hypoglycaemic [3.5], normo
[3.5−7.7] and hyper [7.8]) for consecutive 6-hourly periods throughout the day,
during which time they carried out their usual daily activities.
Results: The table summarises the % time spent during each quarter. Subjects had
greater overall glucose levels in the evening (p = 0.03). Furthermore, the proportion
of normoglycaemic time decreased (p = 0.002) through the day.
Conclusions: This study conﬁrms glucose intolerance increases as the day pro-
gresses and demonstrates the utility of CGM to capture information not available
with a standard OGTT. This questions whether the guidance for the diagnosis of
CFRD should be updated to include tests that can capture evidence of diminished
pancreatic endocrine function later in the day.
Table: Diurnal variation of glycaemic levels
Time (hrs) % time [mean (SD)] spent
hypo (%) normo (%) hyper (%)
0600–1200 10 (16) 80 (16) 9 (11)
1200–1800 5 (7) 78 (17) 17 (18)
1800–0000 6 (11) 68 (22) 25 (17)
0000–0600 7 (9) 81 (18) 12 (17)
Reference(s)
[1] Jarrett, R. BMJ 1(5794): 199–201.
260 Insulin release responses to a mixed meal and standard oral
glucose tolerance test in CF
D. Nazareth1, K. Mohan1, P. Browning2, M. Walshaw1. 1Liverpool Adult CF
Unit, Liverpool, United Kingdom; 2Liverpool Heart and Chest Hospital, Research
Laboratories, Liverpool, United Kingdom
Objectives: Non-glucose dietary constituents inﬂuence the phases of insulin secre-
tion in response to a glycaemic load, and although the early insulin response to
different meal types are well described in normal and diabetic subjects, there have
been no studies comparing both phases in CF. We compared the ﬁrst (1-Ph) and
second (2-Ph) phase insulin responses to a standard mixed meal test (MMT) and
OGTT in CF subjects.
Methods: Following an overnight fast 13 exocrine pancreatic insufﬁcient CF
(without known CFRD) and 10 healthy matched control subjects underwent on
different days a standard OGTT and MMT. 1-Ph and 2-Ph phase were determined
from plasma glucose and insulin.
Results: CF subjects had lower 1-Ph (OGTT: p= 0.002, MMT: p= 0.0002) and 2-Ph
(OGTT: p= 0.002, MMT: p< 0.0001) responses compared to controls. Although the
1-Ph response correlated in both groups (Controls: r = 0.67, p= 0.04; CF: r = 0.92,
p 0.0001), this only correlated with 2-Ph in the CF group (r = 0.63, p= 0.02).
Conclusions: Adult CF patients without known CFRD have diminished ﬁrst and
second phase insulin release. The MMT provides a more physiological alternative to
the OGTT in CF subjects and can be used to assess glucose handling. The clinical
application of the MMT as a standard test for diagnostic purposes in CF merits
further investigation for the early assessment of b-cell function.
